ProShare Advisors’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$84.1K Sell
67,828
-3,744
-5% -$4.64K ﹤0.01% 1903
2025
Q1
$84.5K Sell
71,572
-18,436
-20% -$21.8K ﹤0.01% 1872
2024
Q4
$165K Buy
90,008
+22,215
+33% +$40.7K ﹤0.01% 1945
2024
Q3
$115K Buy
67,793
+17,216
+34% +$29.3K ﹤0.01% 1855
2024
Q2
$69.3K Sell
50,577
-13,493
-21% -$18.5K ﹤0.01% 1711
2024
Q1
$240K Buy
64,070
+5,300
+9% +$19.9K ﹤0.01% 1562
2023
Q4
$577K Buy
58,770
+9,023
+18% +$88.5K ﹤0.01% 962
2023
Q3
$415K Buy
49,747
+84
+0.2% +$701 ﹤0.01% 1010
2023
Q2
$661K Buy
49,663
+1,445
+3% +$19.2K ﹤0.01% 838
2023
Q1
$558K Buy
48,218
+437
+0.9% +$5.06K ﹤0.01% 870
2022
Q4
$391K Buy
47,781
+3,968
+9% +$32.5K ﹤0.01% 1087
2022
Q3
$254K Sell
43,813
-2,716
-6% -$15.7K ﹤0.01% 1244
2022
Q2
$206K Sell
46,529
-17,843
-28% -$79K ﹤0.01% 1459
2022
Q1
$586K Sell
64,372
-14,651
-19% -$133K ﹤0.01% 1179
2021
Q4
$1.62M Buy
79,023
+6,876
+10% +$141K ﹤0.01% 817
2021
Q3
$1.84M Sell
72,147
-13,949
-16% -$356K 0.01% 731
2021
Q2
$3.01M Buy
86,096
+10,662
+14% +$373K 0.01% 630
2021
Q1
$2.51M Buy
75,434
+7,367
+11% +$245K 0.01% 630
2020
Q4
$1.77M Buy
68,067
+19,125
+39% +$496K 0.01% 667
2020
Q3
$483K Buy
48,942
+4,547
+10% +$44.9K ﹤0.01% 955
2020
Q2
$153K Buy
44,395
+14,983
+51% +$51.6K ﹤0.01% 1517
2020
Q1
$90K Sell
29,412
-22,977
-44% -$70.3K ﹤0.01% 1087
2019
Q4
$269K Sell
52,389
-5,231
-9% -$26.9K ﹤0.01% 1409
2019
Q3
$297K Sell
57,620
-1,584
-3% -$8.17K ﹤0.01% 1239
2019
Q2
$358K Sell
59,204
-7,106
-11% -$43K ﹤0.01% 1154
2019
Q1
$479K Buy
66,310
+1,420
+2% +$10.3K ﹤0.01% 1034
2018
Q4
$480K Sell
64,890
-3,819
-6% -$28.3K ﹤0.01% 966
2018
Q3
$372K Sell
68,709
-2,757
-4% -$14.9K ﹤0.01% 1246
2018
Q2
$254K Sell
71,466
-3,716
-5% -$13.2K ﹤0.01% 1480
2018
Q1
$154K Sell
75,182
-2,831
-4% -$5.8K ﹤0.01% 1590
2017
Q4
$206K Buy
78,013
+5,784
+8% +$15.3K ﹤0.01% 1624
2017
Q3
$379K Buy
72,229
+16,798
+30% +$88.1K ﹤0.01% 1065
2017
Q2
$197K Sell
55,431
-3,263
-6% -$11.6K ﹤0.01% 1352
2017
Q1
$303K Sell
58,694
-15,413
-21% -$79.6K ﹤0.01% 1244
2016
Q4
$282K Buy
74,107
+8,300
+13% +$31.6K ﹤0.01% 1405
2016
Q3
$590K Sell
65,807
-8,399
-11% -$75.3K 0.01% 888
2016
Q2
$522K Buy
74,206
+7,057
+11% +$49.6K 0.01% 950
2016
Q1
$571K Sell
67,149
-3,625
-5% -$30.8K 0.01% 938
2015
Q4
$929K Buy
70,774
+7,814
+12% +$103K 0.01% 768
2015
Q3
$230K Sell
62,960
-4,262
-6% -$15.6K ﹤0.01% 1251
2015
Q2
$387K Sell
67,222
-3,451
-5% -$19.9K 0.01% 1204
2015
Q1
$413K Buy
70,673
+11,065
+19% +$64.7K ﹤0.01% 1280
2014
Q4
$467K Buy
59,608
+371
+0.6% +$2.91K 0.01% 1237
2014
Q3
$291K Sell
59,237
-11,589
-16% -$56.9K ﹤0.01% 1740
2014
Q2
$438K Sell
70,826
-28,272
-29% -$175K 0.01% 1668
2014
Q1
$530K Buy
99,098
+66,400
+203% +$355K 0.01% 1824
2013
Q4
$171K Sell
32,698
-20,595
-39% -$108K ﹤0.01% 1269
2013
Q3
$295K Buy
53,293
+15,523
+41% +$85.9K 0.01% 1912
2013
Q2
$95K Buy
+37,770
New +$95K ﹤0.01% 2269